Are we looking for superiority, equivalence, or noninferiority? asking the right question and answering it correctly

Annals of Emergency Medicine

Volumn 55, Issue 5, 2010, Pages 408-411

  Kaji, Amy H ^a,b,c   Lewis, Roger J ^a,b,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; PLACEBO; ANTIINFECTIVE AGENT;

ABSCESS DRAINAGE; ANTIBIOTIC THERAPY; ATTRIBUTABLE RISK; CONFIDENCE INTERVAL; DRUG TREATMENT FAILURE; HUMAN; PRIORITY JOURNAL; REVIEW; SKIN ABSCESS; SKIN INCISION; STATISTICAL SIGNIFICANCE; ABSCESS; BACTERIAL SKIN DISEASE; CHILD; METHODOLOGY; NOTE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ABSCESS; ANTI-BACTERIAL AGENTS; CHILD; DATA INTERPRETATION, STATISTICAL; HUMANS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN DISEASES, BACTERIAL; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 77951919863     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2010.01.024     Document Type: Editorial

References (15)

1. Duong M, Markwell S, Peter J, et al. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med. 2010;55: 401-407.
2. Young KD, Lewis RJ. What is confidence? Part 1: the use and interpretation of confidence intervals. Ann Emerg Med. 1997;30: 307-310. (Pubitemid 27371872)
3. Young KD, Lewis RJ. What is confidence? Part 2: detailed definition and determination of confidence intervals. Ann Emerg Med. 1997;30:311-318. (Pubitemid 27371873)
4. Goodman SN. Toward evidence-based medical statistics. 1: The p value fallacy. Ann Intern Med. 1999;130:995-1004. (Pubitemid 29283991)
5. Blackwelder WC. "Proving the null hypothesis" in clinical trials. Control Clin Trials. 1982;3:345-353. (Pubitemid 13113168)
6. Tamayo-Sarver JH, Albert JM, Tamayo-Sarver M, et al. Advanced statistics: how to determine whether your intervention is different, at least as effective as, or equivalent: a basic introduction. Acad Emerg Med. 2005;12:536-542. (Pubitemid 40732338)
7. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ. 1995;311:485.
8. Flemming TR. Design and interpretation of equivalence trials. Am Heart J. 2000;139:S171-176.
9. Laster LL, Johnson MF. Non-inferiority trials: the "at least as good as" criterion. Stat Med. 2003;22:883-899.
10. Pigeot I, Schafer J, Rohmel J, et al. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo. Stat Med. 2003;22:883-899. (Pubitemid 36322092)
11. Jones B, Jarvis P, Lewis JA, et al. Trials to assess equivalence: the importance of rigorous methods. BMJ. 1996;313:36-39. (Pubitemid 26229889)
12. Greene WL, Concato J, Feinstein AR. Claims of equivalence in medical research: are they supported by the evidence? Ann Intern Med. 2000;132:715-722. (Pubitemid 30244171)
13. Siegel JP. Equivalence and non-inferiority trials. Am Heart J. 2000;139:S166-170.
14. D'Agostino RB, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues\-the encounters of academic consultants in statistics. Stat Med. 2003;22:169-186. (Pubitemid 36163579)
15. Piaggio G, Elbourne DR, Altman DG, et al, for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006; 295:1152-1160. (Pubitemid 43352345)